PubRank

M Schwaninger

Author PubWeight™ 33.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001 3.83
2 NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med 1999 2.96
3 Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 2003 2.44
4 NF-kappaB signaling in cerebral ischemia. Neuroscience 2008 1.88
5 Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke 2000 1.55
6 [Cerebrotendinous xanthomatosis, a treatable metabolic disorder]. Nervenarzt 2002 1.39
7 Cerebrovascular manifestations of Takayasu arteritis in Europe. Rheumatology (Oxford) 2005 1.11
8 Induction of interleukin-6 by depolarization of neurons. J Neurosci 2000 1.10
9 [Fumaric acid or dimethyl fumarate?]. Nervenarzt 2015 1.08
10 Acute inhibition of TAK1 protects against neuronal death in cerebral ischemia. Cell Death Differ 2011 0.98
11 Granzyme-b is involved in mediating post-ischemic neuronal death during focal cerebral ischemia in rat model. Neuroscience 2009 0.96
12 Inhibition of CREB- and cAMP response element-mediated gene transcription by the immunosuppressive drugs cyclosporin A and FK506 in T cells. Naunyn Schmiedebergs Arch Pharmacol 1997 0.93
13 Cerebellar ataxia after repeated hypoglycemia. Eur J Neurol 2002 0.91
14 Bilateral facial palsy: Epstein-Barr virus, not Lyme disease. Eur J Neurol 2006 0.89
15 Characterization of a novel calcium response element in the glucagon gene. J Biol Chem 1999 0.88
16 Characterization of a novel protein kinase C response element in the glucagon gene. Mol Cell Biol 1997 0.88
17 Expression of the kcnk3 potassium channel gene lessens the injury from cerebral ischemia, most likely by a general influence on blood pressure. Neuroscience 2010 0.88
18 The ICAM-1 E469K gene polymorphism is a risk factor for spontaneous cervical artery dissection. Neurology 2006 0.87
19 Calcium-mobilizing insulin secretagogues stimulate transcription that is directed by the cyclic adenosine 3',5'-monophosphate/calcium response element in a pancreatic islet beta-cell line. Endocrinology 1996 0.83
20 A transgenic approach to identify thyroxine transporter-expressing structures in brain development. J Neuroendocrinol 2011 0.82
21 Top concentrations of dynorphin-like immunoreactivity in fractions of rat anterior pituitary cells enriched in gonadotrophs. Life Sci 1986 0.81
22 Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context. Mol Pharmacol 1999 0.81
23 Effect of human growth hormone-releasing hormone on the release of dynorphin-like immunoreactivity, luteinizing hormone, and follicle-stimulating hormone from rat adenohypophysis in vitro. Endocrinology 1987 0.79
24 Clinical and genetic variability of oculodentodigital dysplasia. Clin Genet 2006 0.78
25 Nuclear factor-kappaB activation is not involved in a MPTP model of Parkinson's disease. Neuroreport 2001 0.78
26 The ubiquitin editing enzyme A20 (TNFAIP3) is upregulated during permanent middle cerebral artery occlusion but does not influence disease outcome. Cell Death Dis 2013 0.77
27 Subarachnoid hemorrhage due to Borrelia burgdorferi-associated vasculitis. Eur J Neurol 2006 0.77
28 Truth in the relationship between cancer patient and physician. Ann N Y Acad Sci 1997 0.76
29 Magnetic resonance imaging in Creutzfeldt-Jakob disease: evidence of focal involvement of the cortex. J Neurol Neurosurg Psychiatry 1997 0.76
30 Combined toxicity of penicillin and aspirin therapy may elicit bilateral vestibulopathy. Clin Neurol Neurosurg 2012 0.76
31 Corelease of dynorphin-like immunoreactivity, luteinizing hormone, and follicle-stimulating hormone from rat adenohypophysis in vitro. Endocrinology 1985 0.75
32 Release of dynorphin-like immunoreactivity from rat anterior pituitary gland in vitro. Naunyn Schmiedebergs Arch Pharmacol 1985 0.75
33 [Acute paraplegia]. Radiologe 2004 0.75
34 [Myxedema coma as a rare differential diagnosis of severe consciousness disturbance]. Nervenarzt 2002 0.75
35 [Acute meningitis after transrectal prostate biopsy]. Urologe A 2003 0.75
36 Release of dynorphin-like immunoreactivity from rat adenohypophysis in vitro during inhibition of anterior pituitary hormone secretion from individual cell types. Endocrinology 1987 0.75
37 [Fabry's disease: new therapeutic options for this lysosomal storage disorder]. Nervenarzt 2003 0.75
38 [Symptomatic dissection of the internal carotid artery. A rare manifestation of autosome dominant polycystic kidney disease?]. Nervenarzt 2004 0.75